Current challenges and proposed solutions to the effective implementation of the RTS, S/AS01 Malaria Vaccine Program in sub-Saharan Africa: A systematic review

The Malaria Vaccine Implementation Program, coordinated by the World Health Organization, intended to initiate the roll-out of the RTS, S/AS01 malaria vaccine in 3 sub-Saharan African countries in 2018. With sub-optimal implementation, the effectiveness of this vaccine in routine clinical use could...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:PloS one 2018-12, Vol.13 (12), p.e0209744-e0209744
Hauptverfasser: Dimala, Christian Akem, Kika, Belmond Tse, Kadia, Benjamin Momo, Blencowe, Hannah
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page e0209744
container_issue 12
container_start_page e0209744
container_title PloS one
container_volume 13
creator Dimala, Christian Akem
Kika, Belmond Tse
Kadia, Benjamin Momo
Blencowe, Hannah
description The Malaria Vaccine Implementation Program, coordinated by the World Health Organization, intended to initiate the roll-out of the RTS, S/AS01 malaria vaccine in 3 sub-Saharan African countries in 2018. With sub-optimal implementation, the effectiveness of this vaccine in routine clinical use could be significantly lower than its measured efficacy in randomized trials. This study had as objectives to systematically review and summarize published studies addressing the challenges faced during the implementation phase of malaria vaccination programs and randomized trials conducted in sub-Saharan Africa. The review also sought to report proposed solutions to the challenges identified. This was a systematic review of studies published between 1947 and 2017. Medline, Embase and the Cochrane library databases were searched. Of the 365 studies retrieved, 8 eligible studies reported on challenges of implementing a malaria vaccine in sub-Saharan Africa and possible solutions to these challenges. Data were abstracted from the eligible studies and a qualitative synthesis was done. The 8 studies included in the review had a total of 6189 participants and used a variety of methodologies (3 qualitative, 1 quantitative, 3 mixed method studies and 1 clinical trial review). There was an overall positive acceptance towards the new malaria vaccine (n = 6/8 studies), with a mean acceptance rate of 86.1% (95% CI: 62.0-110.2, n = 2). The main challenges to vaccine receptivity were: inadequate community engagement due to lack of information about the vaccine (n = 6), fear of the vaccine's side effects (n = 5), inefficient delivery of vaccination services to children (n = 4), and sub-optimal quality of the health services (n = 3). Main themes identified from the proposed solutions consisted of the following: using dynamic communication models and trusted sources for delivering vaccine-related health information to the communities (n = 6), community engagement at both national and district level (n = 6), implementing the new vaccine services alongside the existing health services already delivered (n = 6). Effective implementation of the malaria vaccine program requires careful consideration of the socio-cultural context of each community. The RTS, S/AS01 malaria vaccine acceptance and uptake may be significantly enhanced if caregivers' perceptions about vaccines and their importance are adequately fine-tuned. In order to achieve these, community participation and the provision of
doi_str_mv 10.1371/journal.pone.0209744
format Article
fullrecord <record><control><sourceid>proquest_plos_</sourceid><recordid>TN_cdi_plos_journals_2161934994</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_6a6f129284974d46bee4f3657230a2ab</doaj_id><sourcerecordid>2162494436</sourcerecordid><originalsourceid>FETCH-LOGICAL-c526t-63371b4357e4c4c3d22c8cf26d4d7f19aabd3f7514e3e0daa5cca5f4c380e3363</originalsourceid><addsrcrecordid>eNptUttu1DAQjRCIlsIfILDECw_s1rEdZ9MHpNWKS6UiEFt4tSbOeNcrJw52sqhfw6_ivbRqEU-2POecmTk-WfYyp9Ocl_n5xo-hAzftfYdTymhVCvEoO80rziaSUf743v0kexbjhtKCz6R8mp1wWlSy5Ow0-7MYQ8BuIHoNzmG3wkiga0gffO8jNiR6Nw7Wd5EMngxrJGgM6sFukdi2d9gmMuwAxJt9_fv18h1Zns-XNCdfwEGwQH6C1rZD8i34VYCW2I7EsZ4sYQ0BOjI3wWq4IHMSb-KAbdLTJODW4u_n2RMDLuKL43mW_fj44XrxeXL19dPlYn410QWTw0TyZEkteFGi0ELzhjE904bJRjSlySuAuuGmLHKBHGkDUGgNhUnIGUXOJT_LXh90e-ejOnobFctlMlFUlUiIywOi8bBRfbAthBvlwar9gw8rBSEN7lBJkCZnFZuJ9CmNkDWiMFwWJeMUGNRJ6_2x21i32OjkYQD3QPRhpbNrtfJbJXnOGC-SwNujQPC_RoyDam3U6Bx06Mf93ExUQuw3e_MP9P_biQNKBx9jQHM3TE7VLm-3LLXLmzrmLdFe3V_kjnQbMP4XYyjVaw</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2161934994</pqid></control><display><type>article</type><title>Current challenges and proposed solutions to the effective implementation of the RTS, S/AS01 Malaria Vaccine Program in sub-Saharan Africa: A systematic review</title><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Public Library of Science (PLoS)</source><source>PubMed Central</source><source>Free Full-Text Journals in Chemistry</source><creator>Dimala, Christian Akem ; Kika, Belmond Tse ; Kadia, Benjamin Momo ; Blencowe, Hannah</creator><contributor>Naing, Cho</contributor><creatorcontrib>Dimala, Christian Akem ; Kika, Belmond Tse ; Kadia, Benjamin Momo ; Blencowe, Hannah ; Naing, Cho</creatorcontrib><description>The Malaria Vaccine Implementation Program, coordinated by the World Health Organization, intended to initiate the roll-out of the RTS, S/AS01 malaria vaccine in 3 sub-Saharan African countries in 2018. With sub-optimal implementation, the effectiveness of this vaccine in routine clinical use could be significantly lower than its measured efficacy in randomized trials. This study had as objectives to systematically review and summarize published studies addressing the challenges faced during the implementation phase of malaria vaccination programs and randomized trials conducted in sub-Saharan Africa. The review also sought to report proposed solutions to the challenges identified. This was a systematic review of studies published between 1947 and 2017. Medline, Embase and the Cochrane library databases were searched. Of the 365 studies retrieved, 8 eligible studies reported on challenges of implementing a malaria vaccine in sub-Saharan Africa and possible solutions to these challenges. Data were abstracted from the eligible studies and a qualitative synthesis was done. The 8 studies included in the review had a total of 6189 participants and used a variety of methodologies (3 qualitative, 1 quantitative, 3 mixed method studies and 1 clinical trial review). There was an overall positive acceptance towards the new malaria vaccine (n = 6/8 studies), with a mean acceptance rate of 86.1% (95% CI: 62.0-110.2, n = 2). The main challenges to vaccine receptivity were: inadequate community engagement due to lack of information about the vaccine (n = 6), fear of the vaccine's side effects (n = 5), inefficient delivery of vaccination services to children (n = 4), and sub-optimal quality of the health services (n = 3). Main themes identified from the proposed solutions consisted of the following: using dynamic communication models and trusted sources for delivering vaccine-related health information to the communities (n = 6), community engagement at both national and district level (n = 6), implementing the new vaccine services alongside the existing health services already delivered (n = 6). Effective implementation of the malaria vaccine program requires careful consideration of the socio-cultural context of each community. The RTS, S/AS01 malaria vaccine acceptance and uptake may be significantly enhanced if caregivers' perceptions about vaccines and their importance are adequately fine-tuned. In order to achieve these, community participation and the provision of adequate information in an acceptable form via reliable communication channels seem to be imperative.</description><identifier>ISSN: 1932-6203</identifier><identifier>EISSN: 1932-6203</identifier><identifier>DOI: 10.1371/journal.pone.0209744</identifier><identifier>PMID: 30596732</identifier><language>eng</language><publisher>United States: Public Library of Science</publisher><subject>Africa South of the Sahara ; Biology and Life Sciences ; Children ; Clinical trials ; Community involvement ; Community participation ; Data analysis ; Drug delivery systems ; Epidemiology ; Ethics ; Humans ; Immunization ; Immunization Programs - methods ; Immunization Schedule ; Malaria ; Malaria - immunology ; Malaria - prevention &amp; control ; Malaria Vaccines - therapeutic use ; Medicine and Health Sciences ; Mixed methods research ; Mortality ; People and Places ; Public health ; Qualitative analysis ; Randomization ; Research and Analysis Methods ; Reviews ; Side effects ; Social Sciences ; Studies ; Systematic review ; Vaccines ; Vector-borne diseases</subject><ispartof>PloS one, 2018-12, Vol.13 (12), p.e0209744-e0209744</ispartof><rights>2018 Dimala et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2018 Dimala et al 2018 Dimala et al</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c526t-63371b4357e4c4c3d22c8cf26d4d7f19aabd3f7514e3e0daa5cca5f4c380e3363</citedby><cites>FETCH-LOGICAL-c526t-63371b4357e4c4c3d22c8cf26d4d7f19aabd3f7514e3e0daa5cca5f4c380e3363</cites><orcidid>0000-0002-0064-0126 ; 0000-0002-8566-7132</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6312235/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6312235/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,724,777,781,861,882,2096,2915,23847,27905,27906,53772,53774,79349,79350</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30596732$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><contributor>Naing, Cho</contributor><creatorcontrib>Dimala, Christian Akem</creatorcontrib><creatorcontrib>Kika, Belmond Tse</creatorcontrib><creatorcontrib>Kadia, Benjamin Momo</creatorcontrib><creatorcontrib>Blencowe, Hannah</creatorcontrib><title>Current challenges and proposed solutions to the effective implementation of the RTS, S/AS01 Malaria Vaccine Program in sub-Saharan Africa: A systematic review</title><title>PloS one</title><addtitle>PLoS One</addtitle><description>The Malaria Vaccine Implementation Program, coordinated by the World Health Organization, intended to initiate the roll-out of the RTS, S/AS01 malaria vaccine in 3 sub-Saharan African countries in 2018. With sub-optimal implementation, the effectiveness of this vaccine in routine clinical use could be significantly lower than its measured efficacy in randomized trials. This study had as objectives to systematically review and summarize published studies addressing the challenges faced during the implementation phase of malaria vaccination programs and randomized trials conducted in sub-Saharan Africa. The review also sought to report proposed solutions to the challenges identified. This was a systematic review of studies published between 1947 and 2017. Medline, Embase and the Cochrane library databases were searched. Of the 365 studies retrieved, 8 eligible studies reported on challenges of implementing a malaria vaccine in sub-Saharan Africa and possible solutions to these challenges. Data were abstracted from the eligible studies and a qualitative synthesis was done. The 8 studies included in the review had a total of 6189 participants and used a variety of methodologies (3 qualitative, 1 quantitative, 3 mixed method studies and 1 clinical trial review). There was an overall positive acceptance towards the new malaria vaccine (n = 6/8 studies), with a mean acceptance rate of 86.1% (95% CI: 62.0-110.2, n = 2). The main challenges to vaccine receptivity were: inadequate community engagement due to lack of information about the vaccine (n = 6), fear of the vaccine's side effects (n = 5), inefficient delivery of vaccination services to children (n = 4), and sub-optimal quality of the health services (n = 3). Main themes identified from the proposed solutions consisted of the following: using dynamic communication models and trusted sources for delivering vaccine-related health information to the communities (n = 6), community engagement at both national and district level (n = 6), implementing the new vaccine services alongside the existing health services already delivered (n = 6). Effective implementation of the malaria vaccine program requires careful consideration of the socio-cultural context of each community. The RTS, S/AS01 malaria vaccine acceptance and uptake may be significantly enhanced if caregivers' perceptions about vaccines and their importance are adequately fine-tuned. In order to achieve these, community participation and the provision of adequate information in an acceptable form via reliable communication channels seem to be imperative.</description><subject>Africa South of the Sahara</subject><subject>Biology and Life Sciences</subject><subject>Children</subject><subject>Clinical trials</subject><subject>Community involvement</subject><subject>Community participation</subject><subject>Data analysis</subject><subject>Drug delivery systems</subject><subject>Epidemiology</subject><subject>Ethics</subject><subject>Humans</subject><subject>Immunization</subject><subject>Immunization Programs - methods</subject><subject>Immunization Schedule</subject><subject>Malaria</subject><subject>Malaria - immunology</subject><subject>Malaria - prevention &amp; control</subject><subject>Malaria Vaccines - therapeutic use</subject><subject>Medicine and Health Sciences</subject><subject>Mixed methods research</subject><subject>Mortality</subject><subject>People and Places</subject><subject>Public health</subject><subject>Qualitative analysis</subject><subject>Randomization</subject><subject>Research and Analysis Methods</subject><subject>Reviews</subject><subject>Side effects</subject><subject>Social Sciences</subject><subject>Studies</subject><subject>Systematic review</subject><subject>Vaccines</subject><subject>Vector-borne diseases</subject><issn>1932-6203</issn><issn>1932-6203</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>DOA</sourceid><recordid>eNptUttu1DAQjRCIlsIfILDECw_s1rEdZ9MHpNWKS6UiEFt4tSbOeNcrJw52sqhfw6_ivbRqEU-2POecmTk-WfYyp9Ocl_n5xo-hAzftfYdTymhVCvEoO80rziaSUf743v0kexbjhtKCz6R8mp1wWlSy5Ow0-7MYQ8BuIHoNzmG3wkiga0gffO8jNiR6Nw7Wd5EMngxrJGgM6sFukdi2d9gmMuwAxJt9_fv18h1Zns-XNCdfwEGwQH6C1rZD8i34VYCW2I7EsZ4sYQ0BOjI3wWq4IHMSb-KAbdLTJODW4u_n2RMDLuKL43mW_fj44XrxeXL19dPlYn410QWTw0TyZEkteFGi0ELzhjE904bJRjSlySuAuuGmLHKBHGkDUGgNhUnIGUXOJT_LXh90e-ejOnobFctlMlFUlUiIywOi8bBRfbAthBvlwar9gw8rBSEN7lBJkCZnFZuJ9CmNkDWiMFwWJeMUGNRJ6_2x21i32OjkYQD3QPRhpbNrtfJbJXnOGC-SwNujQPC_RoyDam3U6Bx06Mf93ExUQuw3e_MP9P_biQNKBx9jQHM3TE7VLm-3LLXLmzrmLdFe3V_kjnQbMP4XYyjVaw</recordid><startdate>20181231</startdate><enddate>20181231</enddate><creator>Dimala, Christian Akem</creator><creator>Kika, Belmond Tse</creator><creator>Kadia, Benjamin Momo</creator><creator>Blencowe, Hannah</creator><general>Public Library of Science</general><general>Public Library of Science (PLoS)</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QG</scope><scope>7QL</scope><scope>7QO</scope><scope>7RV</scope><scope>7SN</scope><scope>7SS</scope><scope>7T5</scope><scope>7TG</scope><scope>7TM</scope><scope>7U9</scope><scope>7X2</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FD</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABJCF</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>ATCPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>D1I</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB.</scope><scope>KB0</scope><scope>KL.</scope><scope>L6V</scope><scope>LK8</scope><scope>M0K</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>M7S</scope><scope>NAPCQ</scope><scope>P5Z</scope><scope>P62</scope><scope>P64</scope><scope>PATMY</scope><scope>PDBOC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PTHSS</scope><scope>PYCSY</scope><scope>RC3</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0002-0064-0126</orcidid><orcidid>https://orcid.org/0000-0002-8566-7132</orcidid></search><sort><creationdate>20181231</creationdate><title>Current challenges and proposed solutions to the effective implementation of the RTS, S/AS01 Malaria Vaccine Program in sub-Saharan Africa: A systematic review</title><author>Dimala, Christian Akem ; Kika, Belmond Tse ; Kadia, Benjamin Momo ; Blencowe, Hannah</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c526t-63371b4357e4c4c3d22c8cf26d4d7f19aabd3f7514e3e0daa5cca5f4c380e3363</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Africa South of the Sahara</topic><topic>Biology and Life Sciences</topic><topic>Children</topic><topic>Clinical trials</topic><topic>Community involvement</topic><topic>Community participation</topic><topic>Data analysis</topic><topic>Drug delivery systems</topic><topic>Epidemiology</topic><topic>Ethics</topic><topic>Humans</topic><topic>Immunization</topic><topic>Immunization Programs - methods</topic><topic>Immunization Schedule</topic><topic>Malaria</topic><topic>Malaria - immunology</topic><topic>Malaria - prevention &amp; control</topic><topic>Malaria Vaccines - therapeutic use</topic><topic>Medicine and Health Sciences</topic><topic>Mixed methods research</topic><topic>Mortality</topic><topic>People and Places</topic><topic>Public health</topic><topic>Qualitative analysis</topic><topic>Randomization</topic><topic>Research and Analysis Methods</topic><topic>Reviews</topic><topic>Side effects</topic><topic>Social Sciences</topic><topic>Studies</topic><topic>Systematic review</topic><topic>Vaccines</topic><topic>Vector-borne diseases</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Dimala, Christian Akem</creatorcontrib><creatorcontrib>Kika, Belmond Tse</creatorcontrib><creatorcontrib>Kadia, Benjamin Momo</creatorcontrib><creatorcontrib>Blencowe, Hannah</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Animal Behavior Abstracts</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Ecology Abstracts</collection><collection>Entomology Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Meteorological &amp; Geoastrophysical Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Agricultural Science Collection</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Materials Science &amp; Engineering Collection</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>Advanced Technologies &amp; Aerospace Collection</collection><collection>Agricultural &amp; Environmental Science Collection</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Technology Collection</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Materials Science Collection</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Materials Science Database</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Meteorological &amp; Geoastrophysical Abstracts - Academic</collection><collection>ProQuest Engineering Collection</collection><collection>ProQuest Biological Science Collection</collection><collection>Agricultural Science Database</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Engineering Database</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Advanced Technologies &amp; Aerospace Database</collection><collection>ProQuest Advanced Technologies &amp; Aerospace Collection</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Environmental Science Database</collection><collection>Materials Science Collection</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>Engineering Collection</collection><collection>Environmental Science Collection</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>PloS one</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Dimala, Christian Akem</au><au>Kika, Belmond Tse</au><au>Kadia, Benjamin Momo</au><au>Blencowe, Hannah</au><au>Naing, Cho</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Current challenges and proposed solutions to the effective implementation of the RTS, S/AS01 Malaria Vaccine Program in sub-Saharan Africa: A systematic review</atitle><jtitle>PloS one</jtitle><addtitle>PLoS One</addtitle><date>2018-12-31</date><risdate>2018</risdate><volume>13</volume><issue>12</issue><spage>e0209744</spage><epage>e0209744</epage><pages>e0209744-e0209744</pages><issn>1932-6203</issn><eissn>1932-6203</eissn><abstract>The Malaria Vaccine Implementation Program, coordinated by the World Health Organization, intended to initiate the roll-out of the RTS, S/AS01 malaria vaccine in 3 sub-Saharan African countries in 2018. With sub-optimal implementation, the effectiveness of this vaccine in routine clinical use could be significantly lower than its measured efficacy in randomized trials. This study had as objectives to systematically review and summarize published studies addressing the challenges faced during the implementation phase of malaria vaccination programs and randomized trials conducted in sub-Saharan Africa. The review also sought to report proposed solutions to the challenges identified. This was a systematic review of studies published between 1947 and 2017. Medline, Embase and the Cochrane library databases were searched. Of the 365 studies retrieved, 8 eligible studies reported on challenges of implementing a malaria vaccine in sub-Saharan Africa and possible solutions to these challenges. Data were abstracted from the eligible studies and a qualitative synthesis was done. The 8 studies included in the review had a total of 6189 participants and used a variety of methodologies (3 qualitative, 1 quantitative, 3 mixed method studies and 1 clinical trial review). There was an overall positive acceptance towards the new malaria vaccine (n = 6/8 studies), with a mean acceptance rate of 86.1% (95% CI: 62.0-110.2, n = 2). The main challenges to vaccine receptivity were: inadequate community engagement due to lack of information about the vaccine (n = 6), fear of the vaccine's side effects (n = 5), inefficient delivery of vaccination services to children (n = 4), and sub-optimal quality of the health services (n = 3). Main themes identified from the proposed solutions consisted of the following: using dynamic communication models and trusted sources for delivering vaccine-related health information to the communities (n = 6), community engagement at both national and district level (n = 6), implementing the new vaccine services alongside the existing health services already delivered (n = 6). Effective implementation of the malaria vaccine program requires careful consideration of the socio-cultural context of each community. The RTS, S/AS01 malaria vaccine acceptance and uptake may be significantly enhanced if caregivers' perceptions about vaccines and their importance are adequately fine-tuned. In order to achieve these, community participation and the provision of adequate information in an acceptable form via reliable communication channels seem to be imperative.</abstract><cop>United States</cop><pub>Public Library of Science</pub><pmid>30596732</pmid><doi>10.1371/journal.pone.0209744</doi><orcidid>https://orcid.org/0000-0002-0064-0126</orcidid><orcidid>https://orcid.org/0000-0002-8566-7132</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1932-6203
ispartof PloS one, 2018-12, Vol.13 (12), p.e0209744-e0209744
issn 1932-6203
1932-6203
language eng
recordid cdi_plos_journals_2161934994
source MEDLINE; DOAJ Directory of Open Access Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Public Library of Science (PLoS); PubMed Central; Free Full-Text Journals in Chemistry
subjects Africa South of the Sahara
Biology and Life Sciences
Children
Clinical trials
Community involvement
Community participation
Data analysis
Drug delivery systems
Epidemiology
Ethics
Humans
Immunization
Immunization Programs - methods
Immunization Schedule
Malaria
Malaria - immunology
Malaria - prevention & control
Malaria Vaccines - therapeutic use
Medicine and Health Sciences
Mixed methods research
Mortality
People and Places
Public health
Qualitative analysis
Randomization
Research and Analysis Methods
Reviews
Side effects
Social Sciences
Studies
Systematic review
Vaccines
Vector-borne diseases
title Current challenges and proposed solutions to the effective implementation of the RTS, S/AS01 Malaria Vaccine Program in sub-Saharan Africa: A systematic review
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-19T14%3A18%3A31IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_plos_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Current%20challenges%20and%20proposed%20solutions%20to%20the%20effective%20implementation%20of%20the%20RTS,%20S/AS01%20Malaria%20Vaccine%20Program%20in%20sub-Saharan%20Africa:%20A%20systematic%20review&rft.jtitle=PloS%20one&rft.au=Dimala,%20Christian%20Akem&rft.date=2018-12-31&rft.volume=13&rft.issue=12&rft.spage=e0209744&rft.epage=e0209744&rft.pages=e0209744-e0209744&rft.issn=1932-6203&rft.eissn=1932-6203&rft_id=info:doi/10.1371/journal.pone.0209744&rft_dat=%3Cproquest_plos_%3E2162494436%3C/proquest_plos_%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2161934994&rft_id=info:pmid/30596732&rft_doaj_id=oai_doaj_org_article_6a6f129284974d46bee4f3657230a2ab&rfr_iscdi=true